Lv1
88 积分 2021-11-12 加入
The right drug, the wrong assay: TROP2-ADC assessment in breast cancer
51分钟前
待确认
Identification of MDM4 as a Prognostic Biomarker and a Target for Therapeutics in Colorectal Cancer
1天前
已完结
Resurrecting p53 by an Artificial Nano‐Protein for Potent Photodynamic Retinoblastoma Therapy
1天前
已完结
Zongertinib to Target HER2-Driven Resistance in EGFR Mutation-Positive NSCLC: A Case Report
1个月前
已关闭
A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers
3个月前
已完结
A case of Large Cell Neuroendocrine Carcinoma (LCNEC) treated with tarlatamab
3个月前
已完结
Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial
3个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1年前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
1年前
已完结
Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial
1年前
已关闭